Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Clinical studies have proven that there has been a significant decrease in body weight for participants using semaglutide GLP-1 compared to those on a placebo
Semaglutide trials, by contrast, measure weight loss as a primary outcome, track metabolic changes, and monitor safety across thousands of participants over months
Yes, the use of semaglutide, the active ingredient in Wegovy and Ozempic, has been associated with an increased risk of diabetic retinopathy
However, Chemist4U does prescribe Wegovy, which uses the same ingredient as Ozempic at different doses to target weight loss
In our A Closer Look video, HS Connect breaks down biologic treatment options for hidradenitis suppurativa (HS) in a clear, patient-friendly way
